Current Report Filing (8-k)
September 12 2016 - 7:46AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION
13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of
earliest event reported):
September 12, 2016
GERON
CORPORATION
(Exact name of
registrant as specified in its charter)
___________
Delaware
|
|
0-20859
|
|
75-2287752
|
(State or
other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
incorporation)
|
|
|
|
Identification
No.)
|
149 COMMONWEALTH DRIVE,
SUITE 2070
MENLO PARK, CALIFORNIA 94025
(Address of principal executive offices, including
zip code)
(650)
473-7700
(Registrants
telephone number, including area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 8.01. Other Events.
On September 12, 2016,
Geron Corporation issued a press release entitled Geron Provides Update on
Imetelstat Trials Being Conducted by Janssen. A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference.
Item 9.01. Financial
Statements and Exhibits.
(d) Exhibits.
|
Exhibit
No.
|
|
Description
|
|
99.1
|
|
Press release dated September 12, 2016,
entitled Geron Provides Update on Imetelstat Trials Being Conducted by
Janssen.
|
2
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
GERON
CORPORATION
|
|
Date:
September 12, 2016
|
By:
|
/s/ Stephen N. Rosenfield
|
|
Name:
|
Stephen N.
Rosenfield
|
|
Title:
|
Executive
Vice President,
|
|
|
General
Counsel and
|
|
|
Corporate
Secretary
|
3
EXHIBIT
INDEX
Exhibit No.
|
|
Description
|
99.1
|
|
Press release dated September 12, 2016,
entitled Geron Provides Update on Imetelstat Trials Being Conducted by
Janssen.
|
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2023 to Apr 2024